Dr. Dennis Kunimoto

Professor / Vice Dean Faculty Affairs

Faculty of Medicine & Dentistry

2J2.03 Walter C MacKenzie Health Sciences Centre
dennis.kunimoto@ualberta.ca

About Me

Dr. Dennis Kunimoto is currently appointed as Professor / Vice Dean Faculty Affairs in the Faculty of Medicine & Dentistry in the Faculty of Medicine and Dentistry.

- Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
- Author(s): Gupta N, Vedi S, Kunimoto DY, Agrawal B, Kumar R,
- Journal: Vaccine
- Volume: 34
- Issue: 46
- Page(s): 5677-5688
- Publication Year: 2017
- PMID: 27693020
- Investigation of C-5 alkynyl (alkynyloxy or hydroxymethyl) and/or N-3 propynyl substituted pyrimidine nucleoside analogs as a new class of antimicrobial agents.
- Author(s): Garg S, Shakya N, Srivastav NC, Agrawal B, Kunimoto DY, Kumar R,
- Journal: Bioorg Med Chem
- Volume: 24
- Issue: 21
- Page(s): 5521-5533
- Publication Year: 2017
- PMID: 27665179
- Understanding the pathophysiology of the human TB lung granuloma using in vitro granuloma models.
- Author(s): Bhavanam S, Rayat GR, Keelan M, Kunimoto D, Drews SJ,
- Journal: Future Microbiol
- Volume: 11
- Page(s): 1073-89
- Publication Year: 2017
- PMID: 27501829
- Determination of the Volume of Distribution for Pyrazinamide and Ethambutol in the Treatment of Mycobacterium tuberculosis at the Edmonton TB Clinic using Serum Drug Levels
- Author(s): Chen JZ, Kunimoto, D
- Volume: 1
- Issue: 1
- Page(s): 39
- Publication Year: 2016

Faculty

Dr. Dennis Kunimoto

Professor / Vice Dean Faculty Affairs

Faculty of Medicine & Dentistry

About Me

Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.

Investigation of C-5 alkynyl (alkynyloxy or hydroxymethyl) and/or N-3 propynyl substituted pyrimidine nucleoside analogs as a new class of antimicrobial agents.

Understanding the pathophysiology of the human TB lung granuloma using in vitro granuloma models.

Determination of the Volume of Distribution for Pyrazinamide and Ethambutol in the Treatment of Mycobacterium tuberculosis at the Edmonton TB Clinic using Serum Drug Levels

A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 or Genotype 3 Infection (SURVEYOR-II)